drugset / Trial / NCT07261631
Phase I Study of [177Lu]Lu-DFC413 in Patients With Solid Tumors
NaSingle-groupOpen-labelTreatment
Summary
The purpose of this study is to evaluate the safety, tolerability, dosimetry and preliminary efficacy of \[177Lu\]Lu-DFC413 and safety and imaging properties of \[68Ga\]Ga-NNS309 in patients aged ≥ 18 years with solid tumors
Timeline
- Start
- 2025-11-24
- Primary completion
- 2029-05-09
- Completion
- 2029-05-09
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | 177Lu-DFC413 | Unknown | — | — |
| Subject | 68Ga-NNS309 | Diagnostic / imaging agent | — | — |